Stock Scorecard
Stock Summary for Masimo Corp (MASI) - $150.25 as of 10/8/2025 4:19:39 PM EST
Total Score
5 out of 30
Safety Score
49 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MASI
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MASI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MASI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MASI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MASI (49 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Financial Details for MASI
Company Overview |
|
|---|---|
| Ticker | MASI |
| Company Name | Masimo Corp |
| Country | USA |
| Description | Masimo Corporation is a leading innovator in non-invasive monitoring technologies, providing advanced solutions that enhance patient care and streamline healthcare operations worldwide. Headquartered in Irvine, California, Masimo's cutting-edge products, including its proprietary pulse oximetry and non-invasive biometrics, are widely utilized in hospitals and other clinical settings. With a commitment to improving patient outcomes and driving efficiency, the company continues to expand its offerings in the rapidly evolving healthcare technology landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 150.25 |
| Price 4 Years Ago | 292.78 |
| Last Day Price Updated | 10/8/2025 4:19:39 PM EST |
| Last Day Volume | 1,130,269 |
| Average Daily Volume | 666,190 |
| 52-Week High | 194.88 |
| 52-Week Low | 133.70 |
| Last Price to 52 Week Low | 12.38% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 44.24 |
| Sector PE | 41.70 |
| 5-Year Average PE | 49.86 |
| Free Cash Flow Ratio | 54.64 |
| Industry Free Cash Flow Ratio | 37.96 |
| Sector Free Cash Flow Ratio | 30.25 |
| Current Ratio Most Recent Quarter | 2.14 |
| Total Cash Per Share | 2.75 |
| Book Value Per Share Most Recent Quarter | 19.20 |
| Price to Book Ratio | 7.61 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.02 |
| Price to Sales Ratio Twelve Trailing Months | 3.72 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.50 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.22 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 54,325,000 |
| Market Capitalization | 8,162,331,250 |
| Institutional Ownership | 110.07% |
Dividends |
|
| Ex-Dividend Date | 11/23/2012 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 1.0000 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -63.64% |
| 3-Year Dividend Growth Rate Percentage | -63.64% |
| 5-Year Dividend Growth Rate Percentage | -63.64% |
| All-Time Dividend Growth Rate Percentage | -63.64% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 214.40% |
| Annual Earnings Growth | -474.11% |
| Reported EPS 12 Trailing Months | -5.10 |
| Reported EPS Past Year | 2.19 |
| Reported EPS Prior Year | 4.18 |
| Net Income Twelve Trailing Months | -459,200,000 |
| Net Income Past Year | -304,900,000 |
| Net Income Prior Year | 81,500,000 |
| Quarterly Revenue Growth YOY | 7.90% |
| 5-Year Revenue Growth | 17.43% |
| Operating Margin Twelve Trailing Months | 17.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 149,600,000 |
| Total Cash Past Year | 177,600,000 |
| Total Cash Prior Year | 163,000,000 |
| Net Cash Position Most Recent Quarter | -449,100,000 |
| Net Cash Position Past Year | -550,300,000 |
| Long Term Debt Past Year | 727,900,000 |
| Long Term Debt Prior Year | 871,700,000 |
| Total Debt Most Recent Quarter | 598,700,000 |
| Equity to Debt Ratio Past Year | 0.59 |
| Equity to Debt Ratio Most Recent Quarter | 0.64 |
| Total Stockholder Equity Past Year | 1,051,900,000 |
| Total Stockholder Equity Prior Year | 1,364,800,000 |
| Total Stockholder Equity Most Recent Quarter | 1,042,800,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 148,400,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.73 |
| Free Cash Flow Past Year | 176,400,000 |
| Free Cash Flow Prior Year | 50,100,000 |
Options |
|
| Put/Call Ratio | 0.50 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.60 |
| MACD Signal | -1.47 |
| 20-Day Bollinger Lower Band | 134.69 |
| 20-Day Bollinger Middle Band | 154.57 |
| 20-Day Bollinger Upper Band | 174.45 |
| Beta | 1.28 |
| RSI | 54.34 |
| 50-Day SMA | 161.19 |
| 150-Day SMA | 143.05 |
| 200-Day SMA | 147.89 |
System |
|
| Modified | 10/7/2025 4:07:01 AM EST |